143 related articles for article (PubMed ID: 27244881)
21. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
Hari Y; Harashima N; Tajima Y; Harada M
Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
[TBL] [Abstract][Full Text] [Related]
22. 32-Phosphorus selectively delivered by listeria to pancreatic cancer demonstrates a strong therapeutic effect.
Chandra D; Selvanesan BC; Yuan Z; Libutti SK; Koba W; Beck A; Zhu K; Casadevall A; Dadachova E; Gravekamp C
Oncotarget; 2017 Mar; 8(13):20729-20740. PubMed ID: 28186976
[TBL] [Abstract][Full Text] [Related]
23. Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo.
Spruce BA; Campbell LA; McTavish N; Cooper MA; Appleyard MV; O'Neill M; Howie J; Samson J; Watt S; Murray K; McLean D; Leslie NR; Safrany ST; Ferguson MJ; Peters JA; Prescott AR; Box G; Hayes A; Nutley B; Raynaud F; Downes CP; Lambert JJ; Thompson AM; Eccles S
Cancer Res; 2004 Jul; 64(14):4875-86. PubMed ID: 15256458
[TBL] [Abstract][Full Text] [Related]
24. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.
Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER
Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874
[TBL] [Abstract][Full Text] [Related]
25. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
Yagoda N; von Rechenberg M; Zaganjor E; Bauer AJ; Yang WS; Fridman DJ; Wolpaw AJ; Smukste I; Peltier JM; Boniface JJ; Smith R; Lessnick SL; Sahasrabudhe S; Stockwell BR
Nature; 2007 Jun; 447(7146):864-8. PubMed ID: 17568748
[TBL] [Abstract][Full Text] [Related]
26. Dosing Time-Dependent Changes in the Anti-tumor Effect of xCT Inhibitor Erastin in Human Breast Cancer Xenograft Mice.
Shiromizu S; Yamauchi T; Kusunose N; Matsunaga N; Koyanagi S; Ohdo S
Biol Pharm Bull; 2019; 42(11):1921-1925. PubMed ID: 31685775
[TBL] [Abstract][Full Text] [Related]
27. Effect of attachment site on stability of cleavable antibody drug conjugates.
Dorywalska M; Strop P; Melton-Witt JA; Hasa-Moreno A; Farias SE; Galindo Casas M; Delaria K; Lui V; Poulsen K; Loo C; Krimm S; Bolton G; Moine L; Dushin R; Tran TT; Liu SH; Rickert M; Foletti D; Shelton DL; Pons J; Rajpal A
Bioconjug Chem; 2015 Apr; 26(4):650-9. PubMed ID: 25643134
[TBL] [Abstract][Full Text] [Related]
28. Dancing of the second aromatic residue around the 6,8-diazabicyclo[3.2.2]nonane framework: influence on sigma receptor affinity and cytotoxicity.
Holl R; Schepmann D; Fröhlich R; Grünert R; Bednarski PJ; Wünsch B
J Med Chem; 2009 Apr; 52(7):2126-37. PubMed ID: 19243173
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic sigma-2 ligands trigger cancer cell death via cholesterol-induced-ER-stress.
Takchi R; Prudner BC; Gong Q; Hagi T; Newcomer KF; Jin LX; Vangveravong S; Van Tine BA; Hawkins WG; Spitzer D
Cell Death Dis; 2024 May; 15(5):309. PubMed ID: 38697978
[TBL] [Abstract][Full Text] [Related]
30. Exploiting a Rose Bengal-bearing, oxygen-producing nanoparticle for SDT and associated immune-mediated therapeutic effects in the treatment of pancreatic cancer.
Nicholas D; Nesbitt H; Farrell S; Logan K; McMullin E; Gillan T; Kelly P; O'Rourke D; Porter S; Thomas K; O'Hagan BMG; Nomikou N; Callan B; Callan JF; McHale AP
Eur J Pharm Biopharm; 2021 Jun; 163():49-59. PubMed ID: 33798727
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, σ₁, σ₂-receptors binding affinity and antiproliferative action of new C1-substituted adamantanes.
Riganas S; Papanastasiou I; Foscolos GB; Tsotinis A; Bourguignon JJ; Serin G; Mirjolet JF; Dimas K; Kourafalos VN; Eleutheriades A; Moutsos VI; Khan H; Georgakopoulou S; Zaniou A; Prassa M; Theodoropoulou M; Pondiki S; Vamvakides A
Bioorg Med Chem; 2012 May; 20(10):3323-31. PubMed ID: 22512908
[TBL] [Abstract][Full Text] [Related]
32. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
Roh JL; Kim EH; Jang HJ; Park JY; Shin D
Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
[TBL] [Abstract][Full Text] [Related]
33. Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress.
Ostenfeld MS; Fehrenbacher N; Høyer-Hansen M; Thomsen C; Farkas T; Jäättelä M
Cancer Res; 2005 Oct; 65(19):8975-83. PubMed ID: 16204071
[TBL] [Abstract][Full Text] [Related]
34. The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression.
Miyake K; Nishioka M; Imura S; Batmunkh E; Uto Y; Nagasawa H; Hori H; Shimada M
Exp Cell Res; 2012 Aug; 318(13):1554-63. PubMed ID: 22472348
[TBL] [Abstract][Full Text] [Related]
35. Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment.
Yu D; Li W; Zhang Y; Zhang B
Biomed Pharmacother; 2016 Oct; 83():1428-1435. PubMed ID: 27592131
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and in vitro Evaluation of Novel Indole-Based Sigma Receptors Ligands.
Yarim M; Koksal M; Schepmann D; Wünsch B
Chem Biol Drug Des; 2011 Nov; 78(5):869-75. PubMed ID: 21848665
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of conformationally restricted σ(1) receptor ligands with 7,9-diazabicyclo[4.2.2]decane scaffold.
Sunnam SK; Schepmann D; Rack E; Fröhlich R; Korpis K; Bednarski PJ; Wünsch B
Org Biomol Chem; 2010 Dec; 8(24):5525-40. PubMed ID: 20953473
[TBL] [Abstract][Full Text] [Related]
38. Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death.
Kwon MY; Park E; Lee SJ; Chung SW
Oncotarget; 2015 Sep; 6(27):24393-403. PubMed ID: 26405158
[TBL] [Abstract][Full Text] [Related]
39. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
[TBL] [Abstract][Full Text] [Related]
40. The Anticancer Effects of Novel α-Bisabolol Derivatives Against Pancreatic Cancer.
Murata Y; Kokuryo T; Yokoyama Y; Yamaguchi J; Miwa T; Shibuya M; Yamamoto Y; Nagino M
Anticancer Res; 2017 Feb; 37(2):589-598. PubMed ID: 28179305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
